Cargando…
Nivolumab-Induced Colitis in a Patient With Esophageal Adenocarcinoma: A Case Report
Nivolumab is an immune checkpoint inhibitor used in the treatment of several types of cancer. Among the adverse effects of this drug, immune-mediated colitis (IMC) has been described. However, in contrast to other checkpoint inhibitors, such as ipilimumab, drug-induced colitis due to nivolumab is no...
Autores principales: | Vlachos, Iakovos, Karamanolis, Georgios, Vezakis, Antonios, Dellaportas, Dionysios, Myoteri, Despoina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442715/ https://www.ncbi.nlm.nih.gov/pubmed/37614260 http://dx.doi.org/10.7759/cureus.42315 |
Ejemplares similares
-
Granulomatous Peritonitis Secondary to Primary Sclerosing Cholangitis
por: Ketsekioulafis, Ioannis, et al.
Publicado: (2023) -
Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma
por: Myoteri, Despoina, et al.
Publicado: (2017) -
Pancreatic intraductal papillary mucinous neoplasm masquerading as ampullary adenoma: a diagnostic puzzle
por: Dellaportas, Dionysios, et al.
Publicado: (2020) -
Primary Angiosarcoma of the Spleen: An Oncological Enigma
por: Despoina, Myoteri, et al.
Publicado: (2014) -
Erratum to “Primary Angiosarcoma of the Spleen: An Oncological Enigma”
por: Myoteri, Despoina, et al.
Publicado: (2019)